Home » Topics » BioWorld Science

BioWorld Science
RSS

Sichuan Kelun-Biotech Biopharmaceutical patents C-C chemokine receptor type 2/5 antagonists

Aug. 22, 2019

Placental growth factor may be autoimmune disease target

Aug. 22, 2019

Pfizer identifies Gly12Cys mutant GTPase KRas inhibitors

Aug. 22, 2019

Bruton tyrosine kinase inhibitors discovered at Merck & Co.

Aug. 22, 2019

Eisai describes new aldehyde dehydrogenase-2 activators

Aug. 22, 2019

Results presented from phase III HOPE study of voxelotor in sickle cell disease

Aug. 22, 2019

Discovery and preclinical evaluation of SH-379 as a novel anti-LOH agent

Aug. 22, 2019

Discovery of novel antisense oligonucleotides for the treatment of prion disease

Aug. 22, 2019

Shinkei Therapeutics files IND application with the FDA for MR-201

Aug. 22, 2019

Phase I data presented for CM-101 subcutaneous formulation

Aug. 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...